Stem definition | Drug id | CAS RN |
---|---|---|
enzymes | 5206 | 130167-68-9 |
Molecule | Description |
---|---|
Synonyms:
|
Pegademase bovine is a modified enzyme used for enzyme replacement therapy for the treatment of severe combined immunodeficiency disease (SCID) associated with a deficiency of adenosine deaminase. In the absence of the ADA enzyme, the purine substrates adenosine and 2'-deoxyadenosine accumulate, causing metabolic abnormalities that are directly toxic to lymphocytes.
|
None
None
Date | Agency | Company | Orphan |
---|---|---|---|
March 21, 1990 | FDA | SIGMA TAU |
None
None
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Dermatofibrosarcoma protuberans | 93.82 | 44.38 | 7 | 4 | 36 | 79744341 |
None
Source | Code | Description |
---|---|---|
ATC | L03AX04 | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS IMMUNOSTIMULANTS IMMUNOSTIMULANTS Other immunostimulants |
FDA CS | M0000379 | Adenosine Deaminase |
FDA EPC | N0000175471 | Bovine Intestinal Adenosine Deaminase |
Disease | Relation | SNOMED_ID | DOID |
---|---|---|---|
Adenosine deaminase deficiency | indication | 44940001 | DOID:5810 |
None
None
None
None
None
None
ID | Source |
---|---|
4020328 | VANDF |
C0164674 | UMLSCUI |
CHEMBL1201703 | ChEMBL_ID |
DB00061 | DRUGBANK_ID |
D05384 | KEGG_DRUG |
CHEMBL1201514 | ChEMBL_ID |
C051409 | MESH_SUPPLEMENTAL_RECORD_UI |
5238 | MMSL |
996 | MMSL |
d01180 | MMSL |
003552 | NDDF |
108743002 | SNOMEDCT_US |
411097008 | SNOMEDCT_US |
215019 | RXNORM |
HW3H7D91F6 | UNII |
None